MedTrace Logo

Unified Protocol: Community Connections

NCT06038721 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1500

Last updated 2025-09-11

No results posted yet for this study

Summary

The purpose of this study is to administer the Unified Protocols for Transdiagnostic Treatment of Emotional Disorders in Children (UP-C) and Adolescents (UP-A) to youth and participants' parents and to examine the efficacy and outcomes of the treatment using standardized measures, questionnaires, interviews. The UP-C and the UP-A are cognitive-behavioral therapies to treat emotional disorders.

Conditions

  • Mental Health Issue
  • Anxiety Disorder
  • Depressive Disorder
  • Parenting

Interventions

BEHAVIORAL

The Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders in Children

The UP-C is administered in-person to parents and children over the course of up to 15 weekly group sessions, which last approximately 90 minutes each.

BEHAVIORAL

The Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders in Adolescents

The UP-A is administered to parents and teens over the course of approximately 15-24 weekly individual sessions, which last approximately 50 minutes each. Sessions can be administered in-person or online, with at least one session occurring in person.

Sponsors & Collaborators

  • The Children's Trust, Miami FL

    collaborator OTHER

  • University of Miami

    lead OTHER

Principal Investigators

  • Jill Ehrenreich-May, PhD · University of Miami

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
7 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-25
Primary Completion
2028-09-01
Completion
2028-09-25

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06038721 on ClinicalTrials.gov